Breaking News Instant updates and real-time market news.

MS

Morgan Stanley

$48.39

-0.03 (-0.06%)

12:54
07/10/18
07/10
12:54
07/10/18
12:54

Morgan Stanley promotes possible CEO successor Ted Pick, FT reports

Morgan Stanley has named Ted Pick to run the company's institutional securities unit as part of a management overhaul, the Financial Times reports. Pick, who previously served as head of sales and trading, is viewed as a potential future CEO alongside other internal contenders, the report notes. The position Pick is filling has essentially been open since the promotion of Colm Kelleher to president at the beginning of 2016, the report says. Reference Link

  • 10

    Jul

  • 18

    Jul

MS Morgan Stanley
$48.39

-0.03 (-0.06%)

04/18/18
BMOC
04/18/18
NO CHANGE
Target $245
BMOC
Market Perform
Goldman Sachs price target raised to $245 from $221 at BMO Capital
BMO Capital analyst James Fotheringham raised his price target on Goldman Sachs (GS) to $245 after the company's Q1 revenue beat, saying it is "back to stealing market share in its core business" as its FICC - fixed income, currencies, and commodities - trading rose 23% vs. a 4% decline for peers. The analyst adds that while Goldman Sachs will continue to experience positive operating leverage, its valuation relative to Morgan Stanley (MS) cannot be justified, favoring the latter based on its greater exposure to higher-multiple asset management businesses. Fotheringham keeps his Market Perform rating on Goldman Sachs.
04/19/18
BMOC
04/19/18
NO CHANGE
Target $72
BMOC
Outperform
Morgan Stanley 'richly deserves' higher valuation multiple, says BMO Capital
BMO Capital analyst James Fotheringham kept his Outperform rating and $72 price target on Morgan Stanley after its Q1 earnings beat while also raising his FY18 EPS view to $4.78 from $4.51. The analyst cites his expectations of higher trading revenues and also points to lower EPS volatility relative to that Goldman Sachs (GS), even though Morgan Stanley's multiple of 9.7-times two-year-forward PE is below Goldman's 10-times.
06/29/18
OPCO
06/29/18
NO CHANGE
Target $88
OPCO
Outperform
Oppenheimer says 'particularly pleased' with Citi's $17.6B share buyback
Following the release of CCAR results for 2018, Oppenheimer analysts Chris Kotowski and Ben Chittenden told investors in a research note that they are "particularly pleased" with Citi's (C) $17.6B share buyback, up 13% from last year and above their $16.5B estimate, while the dividend increase to 45c was also 5c better than expected. The analysts noted that both Goldman (GS) and Morgan Stanley (MS) got "conditional passes" on their capital plans, as both banks "ran a bit afoul" of the supplementary leverage ratio limitation.
07/09/18
GSCO
07/09/18
NO CHANGE
GSCO
Bank of America, Morgan Stanley top ideas into Q2 earnings season, says Goldman Sachs
Goldman Sachs analyst Richard Ramsden expects Bank of America (BAC) and Morgan Stanley (MS) to beat consensus estimates in Q2. The analyst argues that both appear best positioned, while he sees risk for U.S. Bancorp (USB) and JPMorgan (JPM). Ramsden highlights Bank of America given the material valuation dislocation that looks to support the stock over time. Additionally, the analyst expects an expense and NII beat for Morgan Stanley.

TODAY'S FREE FLY STORIES

SVU

Supervalu

$32.49

0.02 (0.06%)

, UNFI

United Natural Foods

$26.97

0.23 (0.86%)

16:03
10/18/18
10/18
16:03
10/18/18
16:03
Hot Stocks
Supervalu stockholders approve merger with United Natural Foods »

Supervalu (SVU) announced…

SVU

Supervalu

$32.49

0.02 (0.06%)

UNFI

United Natural Foods

$26.97

0.23 (0.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 28

    Oct

CP

Canadian Pacific

$199.44

-6.51 (-3.16%)

16:03
10/18/18
10/18
16:03
10/18/18
16:03
Hot Stocks
Canadian Pacific CEO says set up well for remainder of year and beyond »

"This quarter really…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

AKTS

Akoustis

$5.05

-0.7 (-12.17%)

16:03
10/18/18
10/18
16:03
10/18/18
16:03
Syndicate
Akoustis files to sell common stock and $10M in convertible senior notes »

Akoustis announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

OZK

Bank OZK

$34.93

-1.49 (-4.09%)

16:03
10/18/18
10/18
16:03
10/18/18
16:03
Earnings
Bank OZK reports Q3 EPS 58c, consensus 90c »

Reports Q3 NII $220.6M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 29

    Oct

LLNW

Limelight Networks

$5.04

0.09 (1.82%)

16:03
10/18/18
10/18
16:03
10/18/18
16:03
Earnings
Limelight Networks narrows FY18 adjusted EPS view to 14c-17c from 13c-17c »

Consensus 15c. Backs FY18…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 29

    Oct

LLNW

Limelight Networks

$5.04

0.09 (1.82%)

16:02
10/18/18
10/18
16:02
10/18/18
16:02
Earnings
Limelight Networks reports Q3 adjusted EPS 3c, consensus 3c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 29

    Oct

CP

Canadian Pacific

$199.39

-6.56 (-3.19%)

16:02
10/18/18
10/18
16:02
10/18/18
16:02
Hot Stocks
Breaking Hot Stocks news story on Canadian Pacific »

Canadian Pacific reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

CP

Canadian Pacific

$199.39

-6.56 (-3.19%)

16:01
10/18/18
10/18
16:01
10/18/18
16:01
Earnings
Canadian Pacific reports Q3 adjusted EPS C$4.12, consensus C$4.05 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

SRCE

1st Source

$49.10

-0.73 (-1.47%)

16:01
10/18/18
10/18
16:01
10/18/18
16:01
Earnings
1st Source reports Q3 EPS 76c, consensus 89c »

According to Christopher…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

THC

Tenet

$26.74

-0.04 (-0.15%)

, LPNT

LifePoint

$64.53

-0.13 (-0.20%)

16:00
10/18/18
10/18
16:00
10/18/18
16:00
Hot Stocks
Trump says he is in 'total support' of people with pre-existing conditions »

President Donald Trump…

THC

Tenet

$26.74

-0.04 (-0.15%)

LPNT

LifePoint

$64.53

-0.13 (-0.20%)

HCA

HCA Healthcare

$136.43

0.01 (0.01%)

CYH

Community Health

$2.95

0.06 (2.08%)

UHS

Universal Health

$126.23

0.59 (0.47%)

CI

Cigna

$212.50

1.24 (0.59%)

HNT

Health Net

$0.00

(0.00%)

CNC

Centene

$145.91

0.54 (0.37%)

MOH

Molina Healthcare

$142.79

-0.42 (-0.29%)

AET

Aetna

$201.83

0.55 (0.27%)

UNH

UnitedHealth

$266.28

-0.95 (-0.36%)

HUM

Humana

$331.88

3.95 (1.20%)

WCG

WellCare

$318.04

1.79 (0.57%)

ANTM

Anthem

$280.98

1.4 (0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 26

    Oct

  • 29

    Oct

  • 30

    Oct

  • 30

    Oct

  • 30

    Oct

  • 30

    Oct

  • 31

    Oct

  • 31

    Oct

  • 01

    Nov

  • 01

    Nov

  • 01

    Nov

  • 06

    Nov

  • 07

    Nov

  • 14

    Dec

GS

Goldman Sachs

$224.80

-3.41 (-1.49%)

15:59
10/18/18
10/18
15:59
10/18/18
15:59
Hot Stocks
Goldman Sachs pulls out of Saudi Arabia investment conference »

When asked about…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

BKD

Brookdale Senior Living

$8.93

0.175 (2.00%)

15:58
10/18/18
10/18
15:58
10/18/18
15:58
Hot Stocks
Brookdale Senior Living cancels from Credit Suisse conference, Bloomberg says »

Brookdale Senior Living…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 11

    Dec

CORT

Corcept Therapeutics

$12.46

-0.41 (-3.19%)

, TEVA

Teva

$21.25

0.06 (0.28%)

15:51
10/18/18
10/18
15:51
10/18/18
15:51
Hot Stocks
Corcept slides after Teva gets tentative approval for generic version of Korlym »

An ANDA submitted by Teva…

CORT

Corcept Therapeutics

$12.46

-0.41 (-3.19%)

TEVA

Teva

$21.25

0.06 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

GBT

Global Blood Therapeutics

$38.20

2.42 (6.76%)

15:48
10/18/18
10/18
15:48
10/18/18
15:48
Recommendations
Global Blood Therapeutics analyst commentary  »

Piper Jaffray says FDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

ADP

ADP

$142.68

-1.02 (-0.71%)

15:45
10/18/18
10/18
15:45
10/18/18
15:45
Options
ADP call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 31

    Oct

XOMA

Xoma

$14.38

-1.65 (-10.29%)

, NVS

Novartis

$86.17

0.83 (0.97%)

15:40
10/18/18
10/18
15:40
10/18/18
15:40
Hot Stocks
Breaking Hot Stocks news story on Xoma, Novartis »

Xoma drops 15% after…

XOMA

Xoma

$14.38

-1.65 (-10.29%)

NVS

Novartis

$86.17

0.83 (0.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 19

    Oct

  • 19

    Oct

  • 07

    Nov

XOMA

Xoma

$14.38

-1.65 (-10.29%)

15:39
10/18/18
10/18
15:39
10/18/18
15:39
Hot Stocks
Xoma says Novartis disclosed CRL received from FDA for canakinumab »

As previously announced,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HWBK

Hawthorn Bancshares

$23.65

(0.00%)

15:36
10/18/18
10/18
15:36
10/18/18
15:36
Hot Stocks
Hawthorn Bancshares to sell Branson, MO branch »

Hawthorn Bank, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDSO

Medidata

$70.82

1.45 (2.09%)

15:36
10/18/18
10/18
15:36
10/18/18
15:36
Recommendations
Medidata analyst commentary  »

Medidata price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

ISRG

Intuitive Surgical

$523.21

-19.64 (-3.62%)

15:34
10/18/18
10/18
15:34
10/18/18
15:34
Options
Intuitive Surgical options imply 7.3% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

CMCSA

Comcast

$36.11

-0.28 (-0.77%)

15:32
10/18/18
10/18
15:32
10/18/18
15:32
Hot Stocks
Comcast says it is now the largest provider of Gigabit Internet »

Comcast announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

PTLA

Portola Pharmaceuticals

$22.02

-1.65 (-6.97%)

15:21
10/18/18
10/18
15:21
10/18/18
15:21
Hot Stocks
Breaking Hot Stocks news story on Portola Pharmaceuticals »

James E. Flynn reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Dec

ETFC

E-Trade

$48.86

-1.71 (-3.38%)

15:19
10/18/18
10/18
15:19
10/18/18
15:19
Options
E Trade options imply 7.8% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
10/18/18
10/18
15:17
10/18/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
10/18/18
10/18
15:16
10/18/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.